Literature DB >> 1387095

Fibrinogen/fibrin in atherogenesis.

E B Smith1, W D Thompson, L Crosbie, C M Stirk.   

Abstract

Fibrin is a major component of many atherosclerotic plaques. Within the intima there is continuous formation of fibrin, and continuous fibrinolysis. In aortic lesions, a lipoprotein bound to fibrin can be released by incubation with plasmin. Most of this lipoprotein is accounted for by Lp(a). The atherogenicity of Lp(a) may be more associated with lipid deposition than with inhibition of fibrinolysis. Fibrin degradation products may be chemotactic to monocyte-macrophages and stimulate smooth muscle cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387095     DOI: 10.1007/bf00145356

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  15 in total

Review 1.  Atherosclerosis and the coagulation system.

Authors:  W D Thompson; E B Smith
Journal:  J Pathol       Date:  1989-10       Impact factor: 7.996

2.  Factors relevant to stimulatory activity of fibrin degradation products in vivo.

Authors:  W D Thompson; E B Smith; C M Stirk; A J Stout; A Kochhar
Journal:  Blood Coagul Fibrinolysis       Date:  1990-10       Impact factor: 1.276

3.  Insoluble "fibrin" in human aortic intima. Quantitative studies on the relationship between insoluble "fibrin", soluble fibrinogen and low density lipoprotein.

Authors:  E B Smith; K M Alexander; I B Massie
Journal:  Atherosclerosis       Date:  1976 Jan-Feb       Impact factor: 5.162

4.  The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin.

Authors:  E B Smith; I B Massie; K M Alexander
Journal:  Atherosclerosis       Date:  1976-10       Impact factor: 5.162

5.  Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products.

Authors:  W D Thompson; E B Smith; C M Stirk; A Kochhar
Journal:  Blood Coagul Fibrinolysis       Date:  1990-10       Impact factor: 1.276

6.  Fate of fibrinogen in human arterial intima.

Authors:  E B Smith; G A Keen; A Grant; C Stirk
Journal:  Arteriosclerosis       Date:  1990 Mar-Apr

7.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

8.  Haemostatic factors in human aortic intima.

Authors:  E B Smith; E M Staples
Journal:  Lancet       Date:  1981-05-30       Impact factor: 79.321

9.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

Authors:  D L Eaton; G M Fless; W J Kohr; J W McLean; Q T Xu; C G Miller; R M Lawn; A M Scanu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Fibrinogen as a risk factor for stroke and myocardial infarction.

Authors:  L Wilhelmsen; K Svärdsudd; K Korsan-Bengtsen; B Larsson; L Welin; G Tibblin
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

View more
  4 in total

1.  Pravastatin inhibits C-reactive protein generation induced by fibrinogen, fibrin and FDP in isolated rat vascular smooth muscle cells.

Authors:  Fang Guo; Jun-Tian Liu; Chen-Jing Wang; Xiao-Ming Pang
Journal:  Inflamm Res       Date:  2011-11-17       Impact factor: 4.575

2.  Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.

Authors:  K N Lee; K W Jackson; V J Christiansen; E K Dolence; P A McKee
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

3.  Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.

Authors:  Karsten Suhre; Christa Meisinger; Angela Döring; Elisabeth Altmaier; Petra Belcredi; Christian Gieger; David Chang; Michael V Milburn; Walter E Gall; Klaus M Weinberger; Hans-Werner Mewes; Martin Hrabé de Angelis; H-Erich Wichmann; Florian Kronenberg; Jerzy Adamski; Thomas Illig
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

4.  Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen.

Authors:  A Hara; K Uemura; T Taketomi
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.